XORTX Gross Profit vs Total Other Income Expense Net Analysis

XRTX Stock  USD 1.00  0.06  5.66%   
XORTX Therapeutics financial indicator trend analysis is more than just analyzing XORTX Therapeutics current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether XORTX Therapeutics is a good investment. Please check the relationship between XORTX Therapeutics Gross Profit and its Total Other Income Expense Net accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.

Gross Profit vs Total Other Income Expense Net

Gross Profit vs Total Other Income Expense Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of XORTX Therapeutics Gross Profit account and Total Other Income Expense Net. At this time, the significance of the direction appears to have pay attention.
The correlation between XORTX Therapeutics' Gross Profit and Total Other Income Expense Net is -0.84. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Total Other Income Expense Net in the same time period over historical financial statements of XORTX Therapeutics, assuming nothing else is changed. The correlation between historical values of XORTX Therapeutics' Gross Profit and Total Other Income Expense Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of XORTX Therapeutics are associated (or correlated) with its Total Other Income Expense Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Other Income Expense Net has no effect on the direction of Gross Profit i.e., XORTX Therapeutics' Gross Profit and Total Other Income Expense Net go up and down completely randomly.

Correlation Coefficient

-0.84
Relationship DirectionNegative 
Relationship StrengthSignificant

Gross Profit

Gross profit is a required income statement account that reflects total revenue of XORTX Therapeutics minus its cost of goods sold. It is profit before XORTX Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Total Other Income Expense Net

Most indicators from XORTX Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into XORTX Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.Selling General Administrative is likely to drop to about 996.5 K in 2025. Issuance Of Capital Stock is expected to grow at the current pace this year
 2022 2023 2024 2025 (projected)
Reconciled Depreciation55.5K139.7K160.6K168.7K
Research Development6.5M2.4M2.8M1.6M

XORTX Therapeutics fundamental ratios Correlations

-0.090.780.98-0.29-0.99-0.520.520.990.80.990.740.590.360.891.0-0.38-0.46-0.70.910.27-0.630.590.96-0.150.97
-0.090.36-0.17-0.70.150.070.35-0.15-0.25-0.15-0.22-0.17-0.270.11-0.080.060.020.27-0.22-0.55-0.350.23-0.120.24-0.12
0.780.360.75-0.49-0.8-0.090.440.790.370.790.250.130.120.750.81-0.05-0.12-0.230.57-0.32-0.460.340.80.160.8
0.98-0.170.75-0.25-0.97-0.540.370.970.80.970.720.60.470.780.98-0.42-0.49-0.740.930.27-0.610.590.91-0.170.99
-0.29-0.7-0.49-0.250.20.43-0.33-0.22-0.35-0.22-0.19-0.37-0.36-0.33-0.270.240.310.28-0.340.030.57-0.54-0.150.18-0.31
-0.990.15-0.8-0.970.20.42-0.51-1.0-0.73-1.0-0.67-0.49-0.29-0.89-0.990.30.370.61-0.86-0.210.53-0.47-0.980.09-0.96
-0.520.07-0.09-0.540.430.42-0.33-0.44-0.88-0.44-0.83-0.98-0.69-0.4-0.480.740.80.9-0.77-0.750.79-0.83-0.290.6-0.5
0.520.350.440.37-0.33-0.51-0.330.510.390.510.570.29-0.290.820.52-0.13-0.2-0.240.320.17-0.540.440.580.070.33
0.99-0.150.790.97-0.22-1.0-0.440.510.761.00.690.520.320.890.99-0.31-0.38-0.640.870.24-0.540.50.98-0.120.96
0.8-0.250.370.8-0.35-0.73-0.880.390.760.760.850.930.710.660.76-0.57-0.64-0.940.950.74-0.680.730.64-0.60.78
0.99-0.150.790.97-0.22-1.0-0.440.511.00.760.690.510.320.890.99-0.31-0.38-0.640.870.24-0.540.50.98-0.120.96
0.74-0.220.250.72-0.19-0.67-0.830.570.690.850.690.830.380.650.7-0.65-0.7-0.830.790.67-0.740.790.62-0.310.65
0.59-0.170.130.6-0.37-0.49-0.980.290.520.930.510.830.740.450.55-0.74-0.8-0.920.840.78-0.770.830.37-0.720.58
0.36-0.270.120.47-0.36-0.29-0.69-0.290.320.710.320.380.740.040.33-0.49-0.52-0.730.690.53-0.40.510.12-0.690.5
0.890.110.750.78-0.33-0.89-0.40.820.890.660.890.650.450.040.89-0.22-0.3-0.490.710.22-0.590.490.92-0.090.78
1.0-0.080.810.98-0.27-0.99-0.480.520.990.760.990.70.550.330.89-0.36-0.43-0.660.890.22-0.610.560.97-0.130.97
-0.380.06-0.05-0.420.240.30.74-0.13-0.31-0.57-0.31-0.65-0.74-0.49-0.22-0.360.990.57-0.57-0.40.77-0.78-0.190.47-0.39
-0.460.02-0.12-0.490.310.370.8-0.2-0.38-0.64-0.38-0.7-0.8-0.52-0.3-0.430.990.65-0.64-0.430.84-0.84-0.260.49-0.46
-0.70.27-0.23-0.740.280.610.9-0.24-0.64-0.94-0.64-0.83-0.92-0.73-0.49-0.660.570.65-0.89-0.760.63-0.73-0.50.55-0.7
0.91-0.220.570.93-0.34-0.86-0.770.320.870.950.870.790.840.690.710.89-0.57-0.64-0.890.53-0.70.720.76-0.480.93
0.27-0.55-0.320.270.03-0.21-0.750.170.240.740.240.670.780.530.220.22-0.4-0.43-0.760.53-0.260.380.15-0.650.21
-0.63-0.35-0.46-0.610.570.530.79-0.54-0.54-0.68-0.54-0.74-0.77-0.4-0.59-0.610.770.840.63-0.7-0.26-0.94-0.450.36-0.6
0.590.230.340.59-0.54-0.47-0.830.440.50.730.50.790.830.510.490.56-0.78-0.84-0.730.720.38-0.940.38-0.450.57
0.96-0.120.80.91-0.15-0.98-0.290.580.980.640.980.620.370.120.920.97-0.19-0.26-0.50.760.15-0.450.380.020.9
-0.150.240.16-0.170.180.090.60.07-0.12-0.6-0.12-0.31-0.72-0.69-0.09-0.130.470.490.55-0.48-0.650.36-0.450.02-0.2
0.97-0.120.80.99-0.31-0.96-0.50.330.960.780.960.650.580.50.780.97-0.39-0.46-0.70.930.21-0.60.570.9-0.2
Click cells to compare fundamentals

XORTX Therapeutics Account Relationship Matchups

XORTX Therapeutics fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets2.3M17.3M12.3M5.5M6.3M5.0M
Other Current Liab728.4K229.0K151.4K87.6K78.9K74.9K
Total Current Liabilities1.0M4.2M1.5M294.9K339.2K322.2K
Total Stockholder Equity1.3M13.1M7.0M4.6M5.3M3.1M
Net Debt(171.3K)(14.8M)(10.3M)(3.4M)(3.1M)(3.2M)
Retained Earnings(8.0M)(7.6M)(14.1M)(23.7M)(21.3M)(20.2M)
Accounts Payable305.8K324.0K1.3M195.8K225.2K213.9K
Cash171.3K14.8M10.4M3.4M4.0M3.6M
Non Current Assets Total234.3K1.5M1.5M1.4M1.6M1.7M
Cash And Short Term Investments171.3K14.8M10.4M3.4M3.9M3.6M
Net Receivables14.4K40.7K81.8K60.7K69.8K35.1K
Common Stock Shares Outstanding740.4K1.1M1.5M2.0M2.3M2.4M
Liabilities And Stockholders Equity2.3M17.3M12.3M5.5M6.3M5.0M
Other Stockholder Equity0.05.0M(2.1M)5.8M6.7M7.1M
Total Liab1.0M4.2M5.4M825.9K949.8K1.9M
Total Current Assets2.1M15.8M10.9M4.1M4.7M4.2M
Short Long Term Debt Total43.3K50.8K77.4K11.5K10.4K9.8K
Intangible Assets234.3K201.0K199.4K175.3K157.7K189.0K
Net Tangible Assets(484.1K)1.0M16.5M9.2M10.6M11.1M
Net Invested Capital1.3M16.7M7.0M4.6M5.3M4.6M
Net Working Capital1.0M14.9M9.4M3.8M4.3M4.3M
Common Stock8.3M15.7M15.2M17.1M19.6M10.9M
Other Current Assets1.9M1.0M379.6K560.4K504.4K701.0K
Capital Stock8.3M20.0M15.2M17.1M19.6M13.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for XORTX Stock Analysis

When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.